These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9396055)

  • 1. Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes.
    Xin Z; Sun L; Ganea D
    Peptides; 1997; 18(8):1151-9. PubMed ID: 9396055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines.
    Olszowy MW; Leuchtmann PL; Veillette A; Shaw AS
    J Immunol; 1995 Nov; 155(9):4236-40. PubMed ID: 7594580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation of protein tyrosine kinases p56lck and p59fyn, and altered tyrosine phosphorylation in murine AIDS.
    Trebak M; Lambert CA; Rahmouni S; Greimers R; Boniver J; Moutschen M
    Int Immunol; 1998 Oct; 10(10):1473-80. PubMed ID: 9796914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of the TcR/CD3 complex stimulates p59fyn(T) activity: detection of associated proteins at 72 and 120-130 kD.
    da Silva AJ; Yamamoto M; Zalvan CH; Rudd CE
    Mol Immunol; 1992 Dec; 29(12):1417-25. PubMed ID: 1454062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn.
    Quill H; Riley MP; Cho EA; Casnellie JE; Reed JC; Torigoe T
    J Immunol; 1992 Nov; 149(9):2887-93. PubMed ID: 1357030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human airway epithelial cells stimulate T-lymphocyte lck and fyn tyrosine kinase.
    Kalb TH; Yio XY; Mayer L
    Am J Respir Cell Mol Biol; 1997 Nov; 17(5):561-70. PubMed ID: 9374107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p59fyn tyrosine kinase regulates p56lck tyrosine kinase activity and early TCR-mediated signaling.
    Lee SK; Shaw A; Maher SE; Bothwell AL
    Int Immunol; 1994 Oct; 6(10):1621-7. PubMed ID: 7826952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex.
    Xin Z; Tang H; Ganea D
    J Neuroimmunol; 1994 Oct; 54(1-2):59-68. PubMed ID: 7929804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
    Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
    Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms.
    Wang HY; Jiang X; Gozes I; Fridkin M; Brenneman DE; Ganea D
    Regul Pept; 1999 Oct; 84(1-3):55-67. PubMed ID: 10535409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
    Burgess KE; Yamamoto M; Prasad KV; Rudd CE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients.
    Cayota A; Vuillier F; Siciliano J; Dighiero G
    Int Immunol; 1994 Apr; 6(4):611-21. PubMed ID: 7912546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes.
    Phipps DJ; Reed-Doob P; MacFadden DK; Piovesan JP; Mills GB; Branch DR
    Clin Exp Immunol; 1995 Jun; 100(3):412-8. PubMed ID: 7539724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of protein tyrosine kinases p56lck and p59fyn in T cell development.
    van Oers NS; Garvin AM; Cooke MP; Davis CB; Littman DR; Perlmutter RM; Teh HS
    Adv Exp Med Biol; 1992; 323():89-99. PubMed ID: 1485568
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of p56lck and p59fyn tyrosine kinases and CD45 protein tyrosine phosphatase in T-cell development and clonal selection.
    Penninger JM; Wallace VA; Kishihara K; Mak TW
    Immunol Rev; 1993 Oct; 135():183-214. PubMed ID: 8282313
    [No Abstract]   [Full Text] [Related]  

  • 18. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway.
    Lin K; Abraham KM
    Int Immunol; 1997 Feb; 9(2):291-306. PubMed ID: 9040011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C; Delgado M; Gomariz RP; Ganea D
    J Immunol; 1996 Jun; 156(11):4128-36. PubMed ID: 8666779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-dependent and -independent association of protein tyrosine kinases to the T cell receptor/CD3 complex of CD4+ mouse T lymphocytes.
    Criado G; Feito MJ; Rojo JM
    Eur J Immunol; 1996 Jun; 26(6):1228-34. PubMed ID: 8647197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.